Table 1 Correlation between miR-182-5p expression and HCC clinicopathological parameters
From: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
Parameters | n | miR-182-5p | P value | |
|---|---|---|---|---|
Low (n = 80) | High (n = 39) | |||
Gender | ||||
 Male | 100 | 66 | 34 | 0.602 |
 Female | 19 | 14 | 5 | |
Age (years) | ||||
 < 50 | 30 | 18 | 12 | 0.372 |
 ≥ 50 | 89 | 62 | 27 | |
Cirrhosis | ||||
 Absence | 27 | 22 | 5 | 0.102 |
 Presence | 92 | 58 | 34 | |
Tumor number | ||||
 Single | 96 | 66 | 30 | 0.471 |
 Multiple | 23 | 14 | 9 | |
Tumor size(cm) | ||||
 < 5 cm | 102 | 70 | 32 | 0.418 |
 ≥ 5 | 17 | 10 | 7 | |
Micro vein invasion | ||||
 Absence | 77 | 54 | 23 | 0.416 |
 Presence | 42 | 26 | 16 | |
HBV infection | ||||
 Absence | 16 | 13 | 3 | 0.259 |
 Presence | 103 | 67 | 36 | |
AFP | ||||
 < 20 | 54 | 42 | 12 | 0.031* |
 ≥ 20 | 65 | 38 | 27 | |